Complications in endocrine surgery

Surgical Complications: Diagnosis and Treatment

Volumn , Issue , 2007, Pages 505-566

  Kekis, Panagiotis B ^a   Smith, Simon G T ^a   Lynn, John A ^a   Fleming, William R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58549091371     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860948329_0016     Document Type: Chapter

References (138)

1. Bartsch DK, et al. (2000) Management of nonfunctioning islet cell carcinomas. World J Surg 24: 1418-1424.
2. Geoghegan JG, et al. (1994) Localization and surgical management of insulinoma. Br J Surg 81: 1025-1028.
3. Mullan MH, Gauger PG, Thompson NW. (2001) Endocrine tumours of the pancreas: review and recent advances. ANZ J Surg 71: 475-482.
4. Proye CA. (1998) Endocrine tumours of the pancreas: an update. Aust N Z J Surg 68: 90-100.
5. Gullo L, et al. (2003) Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol 98: 2435-2439.
6. Hochwald SN, Conlon KC, Brennan MF. (2001) Nonfunctional pancreatic islet cell tumors. In: Doherty GM, Skogseid B (eds), Surgical Endocrinology (Lippincott Williams &Wilkins, Philadelphia), pp. 361-373.
7. Lo CY, Chan WF, Lo CM, et al. (2004) Surgical treatment of pancreatic insulinomas in the era of laparoscopy. Surg Endosc 18(2): 297-302.
8. Shimizu S,Tanaka M, Konomi H, et al. (2004) Laparoscopic pancreatic surgery: current indications and surgical results. Surg Endosc 18(3): 402-406.
9. Norton JA, et al. (2003) Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 138: 859-866.
10. Carty SE, Jensen RT,Norton JA. (1992) Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112: 1024-1031.
11. Grant CS. (2001) Insulinoma. In: Doherty GM, Skogseid B (eds), Surgical Endocrinology (Lippincott Williams &Wilkins, Philadelphia), pp. 346-360.
12. Simon D, Starke A, Goretzki PE, Roeher HD. (1998) Reoperative surgery for organic hyperinsulinism: indications and operative strategy. World J Surg 22: 666-671.
13. Thompson GB, et al. (1993) Reoperative insulinomas, 1927 to 1992: an institutional experience. Surgery 114: 1196-1204.
14. Broughan TA, Leslie JD, Soto JM, Hermann RE. (1986) Pancreatic islet cell tumors. Surgery 99: 671-678.
15. Lowney JK, Doherty GM. (2001) Surgery for endocrine tumors of the pancreas. In: Doherty GM, Skogseid B (eds), Surgical Endocrinology (Lippincott Williams &Wilkins, Philadelphia), pp. 381-392.
16. Bieligk S, Jaffe BM. (1995) Islet cell tumors of the pancreas. Surg Clin North Am 75: 1025-1040.
17. Doherty GM, et al. (1991) Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery 110: 989-996.
18. Lo CY, et al. (1997) Pancreatic insulinomas. A 15-year experience. Arch Surg 132: 926-930.
19. Menegaux F, Schmitt G,Mercadier M, Chigot JP. (1993) Pancreatic insulinomas. Am J Surg 165: 243-248.
20. Pasieka JL,McLeod MK,ThompsonNW, Burney RE. (1992) Surgical approach to insulinomas. Assessing the need for preoperative localization. Arch Surg 127: 442-447.
21. Rothmund M, et al. (1990) Surgery for benign insulinoma: an international review.World J Surg 14: 393-398.
22. vanHeerden JA, Edis AJ, Service FJ. (1979) The surgical aspects of insulinomas. Ann Surg 189: 677-682.
23. Richards ML, Gauger PG, Thompson NW, et al. (2002) Pitfalls in the surgical treatment of insulinoma. Surgery 132: 1040-1049.
24. Lo CY, et al. (2000) Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 128: 903-909.
25. Aldridge MC, Williamson RCN. (1993) Surgery of endocrine tumours of the pancreas. In: Lynn JA, Bloom SR (eds), Surgical Endocrinology (Butterworth- Heinemann, Oxford), pp. 503-520.
26. Stefanini P, Carboni M, Patrassi N, Basoli A. (1974) Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 75: 597-609.
27. Boukhman MP, et al. (1998) Insulinoma-experience from 1950 to 1995. West J Med 169: 98-104.
28. Grant CS, van Heerden J, Charboneau JW, et al. (1988) Insulinoma. The value of intraoperative ultrasonography. Arch Surg 123: 843-848.
29. Bottger TC, Junginger T. (1993) Is preoperative radiographic localization of islet cell tumors in patients with insulinoma necessary? World J Surg 17: 427-432.
30. Hashimoto LA, Walsh RM. (1999) Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189: 368-373.
31. Huai JC, et al. (1998) Localization and surgical treatment of pancreatic insulinomas guided by intraoperative ultrasound. Am J Surg 175: 18-21.
32. Machado MC, et al. (2001) Insulinoma: diagnostic strategies and surgical treatment. A 22-year experience. Hepatogastroenterology 48: 854-858.
33. Chapuis Y, Bertrand D. (2002) Laparoscopic enucleation of islet tumors of the pancreas. In:Gagner M, Inabnet WB(eds),Minimally Invasive Endocrine Surgery (Lippincott Williams and Wilkins, Philadelphia), pp. 273-281.
34. Patterson EJ, et al. (2001) Laparoscopic pancreatic resection: single-institution experience of 19 patients. J Am Coll Surg 193: 281-287.
35. Jaroszewski DE, Schlinkert RT, Thompson GB, Schlinkert DK. (2004) Laparoscopic localization and resection of insulinomas. Arch Surg 139: 270-274.
36. Iihara M, Obara T. (2002) Minimally invasive endocrine surgery: laparoscopic resection of insulinomas. Biomed Pharmacother 56(Suppl 1): 227s-230s.
37. Gramatica L Jr. et al. (2002) Videolaparoscopic resection of insulinomas: experience in two institutions.World J Surg 26: 1297-1300.
38. Mabrut JY, et al. (2001) Is preoperative localization of insulinomas necessary? Ann Chir 126: 850-856.
39. Hirshberg B, et al. (2002) Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg 194: 761-764.
40. Boukhman MP, et al. (1999) Localization of insulinomas. Arch Surg 134: 818-822.
41. Nesje LB, Varhaug JE, Husebye ES, Odegaard S. (2002) Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. Scand J Gastroenterol 37: 732-737.
42. Anderson MA, et al. (2000) Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95: 2271-2277.
43. O'Shea D,Rohrer-TheursAW, Lynn JA, et al. (1996) Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab 81: 1623- 1627.
44. Kuzin NM, et al. (1998) Preoperative and intraoperative topographic diagnosis of insulinomas.World J Surg 22: 593-597.
45. Ruckert K,Gunther R. (1982) Is "blind left-pancreatic resection" for insulinoma still indicated? Chirurg 53: 98-102.
46. Cothren CC, Raeburn CD, Chen Y, McIntyre RC Jr. (2003) Insulinoma: identification by EUS and intraoperative US. Gastrointest Endosc 58: 575-576.
47. Norton JA. (1999) Intra-operative procedures to localize endocrine tumours of the pancreas and duodenum. Ital J Gastroenterol Hepatol 31(Suppl 2): S195-197.
48. TuttGOJr, Edis AJ, Service FJ, vanHeerden JA. (1980) Plasma glucose monitoring during operation for insulinoma: a critical reappraisal. Surgery 88: 351-356.
49. Carneiro DM, Levi JU, Irvin GL, III. (2002) Rapid insulin assay for intraoperative confirmation of complete resection of insulinomas. Surgery 132: 937-942.
50. Proye C, et al. (1998) Intraoperative insulin measurement during surgical management of insulinomas.World J Surg 22: 1218-1224.
51. Jensen RT. (2001) Zollinger-Ellison syndrome. In: Doherty GM, Skogseid B (eds), Surgical Endocrinology (Lippincott Williams & Wilkins, Philadelphia), pp. 291-343.
52. Thom AK, Norton JA, Axiotis CA, Jensen RT. (1991) Location, incidence, and malignant potential of duodenal gastrinomas. Surgery 110: 1086-1091.
53. Delcore R Jr, Cheung LY, Friesen SR. (1990) Characteristics of duodenal wall gastrinomas. Am J Surg 160: 621-623.
54. Norton JA, Doppman JL, Jensen RT. (1992) Curative resection in Zollinger- Ellison syndrome. Results of a 10-year prospective study. Ann Surg 215: 8-18.
55. Howard TJ, Zinner MJ, Stabile BE, Passaro E Jr. (1990) Gastrinoma excision for cure. A prospective analysis. Ann Surg 211: 9-14.
56. Sugg SL, et al. (1993) A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 218: 138-144.
57. Stabile BE, Morrow DJ, Passaro E Jr. (1984) The gastrinoma triangle: operative implications. Am J Surg 147: 25-31.
58. Farley DR, van Heerden JA, Grant CS, Thompson GB. (1994) Extrapancreatic gastrinomas. Surgical experience. Arch Surg 129: 506-511.
59. Wolfe MM, Alexander RW,McGuigan JE. (1982) Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery. N Engl J Med 306: 1533-1536.
60. Ellison EH, Wilson SD. (1964) The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases. Ann Surg 160: 512-530.
61. Creutzfeldt W, Arnold R, Creutzfeldt C, Track NS. (1975) Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol 6: 47-76.
62. Fox PS, Hofmann JW,Wilson SD, DeCosse JJ. (1974) Surgical management of the Zollinger-Ellison syndrome. Surg Clin North Am 54: 395-407.
63. Norton JA, et al. (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341: 635-644.
64. Jensen RT. (1996) Gastrointestinal endocrine tumours. Gastrinoma. Baillieres Clin Gastroenterol 10: 603-643.
65. Delcore R, Friesen SR. (1994) The place for curative surgical procedures in the treatment of sporadic and familial Zollinger-Ellison syndrome. Curr Opin Gen Surg 69-76.
66. Orbuch M, Doppman JL, Jensen RT. (1995) Localization of pancreatic endocrine tumors. Semin Gastrointest Dis 6: 90-101.
67. Rothmund M. (1994) Localization of endocrine pancreatic tumours. Br J Surg 81: 164-166.
68. Norton JA,Warren RS, Kelly MG, et al. (2003) Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 134: 1057-1063.
69. Norton JA, et al. (1998) Surgical treatment of localized gastrinoma within the liver: a prospective study. Surgery 124: 1145-1152.
70. Owen NJ, et al. (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74: 968-973.
71. Krenning EP, et al. (1994) Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann NY Acad Sci 733: 416-424.
72. Alexander HR, et al. (1998) Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg 228: 228-238.
73. Cadiot G, et al. (1996) Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison. Gastroenterology 111: 845-854.
74. Gibril F, et al. (1996) Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med 125: 26-34.
75. Bhutani MS. (1999) Endoscopic ultrasound in pancreatic diseases. Indications, limitations, and the future. Gastroenterol Clin North Am 28: 747-770, xi.
76. Thom AK, et al. (1992) Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas. Surgery 112: 1002-1008.
77. Imamura M, et al. (1987) Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 205: 230-239.
78. Cherner JA, et al. (1986) Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment. Ann Intern Med 105: 841-847.
79. Gibril F, et al. (1996) Metastatic gastrinomas: localization with selective arterial injection of secretin. Radiology 198: 77-84.
80. Norton JA. (1999) Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol 10(Suppl 4): 182-184.
81. Frucht H, et al. (1990) Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. Gastroenterology 99: 1622-1627.
82. Jensen RT, Fraker DL. (1994) Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA 271: 1429-1435.
83. Zollinger RM, et al. (1980) Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal. Ann Surg 192: 422-430.
84. Lo CY, et al. (1996) Islet cell carcinoma of the pancreas. World J Surg 20: 878-883.
85. Ellison EC. (1995) Forty-year appraisal of gastrinoma. Back to the future. Ann Surg 222: 511-521.
86. Malagelada JR, Edis AJ, Adson MA, et al. (1983)Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84: 1524-1532.
87. Richardson CT,Walsh JH. (1976) The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome. N Engl J Med 294: 133-135.
88. Richardson CT, et al. (1979) Effect of vagotomy in Zollinger-Ellison syndrome. Gastroenterology 77: 682-686.
89. Pisegna JR, et al. (1992) Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology 102: 767-778.
90. Jensen RT. (1996) Should the 1996 citation for Zollinger-Ellison syndrome read: "Acid-reducing surgery in, aggressive resection out"? Am J Gastroenterol 91: 1067-1070.
91. Jensen RT. (1998) Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243: 477-488.
92. Norton JA, et al. (1987) Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery 102: 958-966.
93. McCarthy DM, et al. (1979) Hyperparathyroidism - a reversible cause of cimetidine-resistant gastric hypersecretion. Br Med J 1: 1765-1766.
94. MacFarlane MP, et al. (1995) Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 118: 973-979.
95. Thompson NW, Bondeson AG, Bondeson L, Vinik A. (1989) The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery 106: 1081-1085.
96. Thompson NW. (1998) Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 243: 495-500.
97. Wynick D, Bloom SR. (1993) Diagnosis and Medical Management of Gastoenteropancreatic Tumours. In: Lynn JA, Bloom SR (eds), Surgical Endocrinology (Butterworth-Heinemann, Oxford), pp. 487-493.
98. Kent RB, III, van Heerden JA, Weiland LH. (1981) Non-functioning islet cell tumors. Ann Surg 193: 185-190.
99. Kloppel G,Heitz PU. (1988) Pancreatic endocrine tumors. Pathol Res Pract 183: 155-168.
100. Grant CS. (1993) Surgical management of malignant islet cell tumors. World J Surg 17: 498-503.
101. Cheslyn-Curtis S, Sitaram V, Williamson RC. (1993) Management of non-functioning neuroendocrine tumours of the pancreas. Br J Surg 80: 625-627.
102. Doherty GM. (2001) Vipoma, glucagonoma and other rare islet cell tumors. In: Doherty GM, Skogseid B (eds), Surgical Endocrinology (Lippincott Williams & Wilkins, Philadelphia), pp. 375-379.
103. Park SK, O'Dorisio MS, O'Dorisio TM. (1996) Vasoactive intestinal polypeptide-secreting tumours: biology and therapy. Baillieres Clin Gastroenterol 10: 673-696.
104. Soga J, Yakuwa Y. (1998) Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases. J Hepatobiliary Pancreat Surg 5: 312-319.
105. Zhang M, et al. (2004) Clinical experience in diagnosis and treatment of glucagonoma syndrome. Hepatobiliary Pancreat Dis Int 3: 473-475.
106. Howard TJ, et al. (1990) Anatomic distribution of pancreatic endocrine tumors. Am J Surg 159: 258-264.
107. Soga J, Yakuwa Y. (1999) Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 18: 13-22.
108. Sano T, Asa SL, Kovacs K. (1988) Growth hormone-releasing hormoneproducing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9: 357-373.
109. Doppman JL, et al. (1994) Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant? Radiology 190: 59-64.
110. Bellows C, Haque S, Jaffe B. (1998) Pancreatic polypeptide islet cell tumor: case report and review of the literature. J Gastrointest Surg 2: 526-532.
111. Heitz PU, Kasper M, Polak JM, Kloppel G. (1982) Pancreatic endocrine tumors. Hum Pathol 13: 263-271.
112. Shulkes A, Boden R, Cook I, et al. (1984) Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide. J Clin Endocrinol Metab 58: 41-48.
113. Strodel WE, et al. (1984) Pancreatic polypeptide-producing tumors. Silent lesions of the pancreas? Arch Surg 119: 508-514.
114. Blackburn AM, Bryant MG, Adrian TE, Bloom SR. (1981) Pancreatic tumours produce neurotensin. J Clin Endocrinol Metab 52: 820-822.
115. Wynick D, et al. (1990) Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein. BMJ 300: 1314-1315.
116. Grama D, et al. (1992) Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes.World J Surg 16: 632-639.
117. Norton JA, et al. (2001) Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger- Ellison syndrome. Ann Surg 234: 495-505.
118. Thompson GB, van Heerden JA, Grant CS, et al. (1988) Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 104: 1011-1017.
119. Tagaya N, et al. (2003) Laparoscopic resection of the pancreas and review of the literature. Surg Endosc 17: 201-206.
120. Chapuis Y, Bigourdan JM,Massault PP, et al. (1998) Videolaparoscopic excision of insulinoma. A study of 5 cases. Chirurgie 123: 461-467.
121. Fabre JM, et al. (2002) Is laparoscopic left pancreatic resection justified? Surg Endosc 16: 1358-1361.
122. Vezakis A, Davides D, Larvin M, McMahon MJ. (1999) Laparoscopic surgery combined with preservation of the spleen for distal pancreatic tumors. Surg Endosc 13: 26-29.
123. Machi J. (1999) Intraoperative and laparoscopic ultrasound. Surg Oncol Clin North Am 8: 205-226.
124. Correnti S, Liverani A, Antonini G, et al. (1996) Intraoperative ultrasonography for pancreatic insulinomas. Hepatogastroenterology 43: 207-211.
125. Machi J, Oishi AJ, Furumoto NL, Oishi RH. (2004) Intraoperative ultrasound. Surg Clin North Am 84: 1085-1111.
126. Ohwada S, et al. (1998) Fibrin glue sandwich prevents pancreatic fistula following distal pancreatectomy.World J Surg 22: 494-498.
127. Suzuki Y, et al. (1999) Randomized clinical trial of ultrasonic dissector or conventional division in distal pancreatectomy for non-fibrotic pancreas. Br J Surg 86: 608-611.
128. Ayav A, Bresler L, Brunaud L, Boissel P. (2004) Laparoscopic approach for solitary insulinoma: a multicentre study. Langenbecks Arch Surg 390: 134-140.
129. Gouillat C, Gigot JF. (2001) Pancreatic surgical complications - the case for prophylaxis. Gut 48(Suppl 4): iv32-39.
130. Sarmiento JM, Farnell MB, Que FG, Nagorney DM. (2002) Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.World J Surg 26: 1267-1271.
131. Chen X, Cai WY, Yang WP, Li HW. (2002) Pancreatic insulinomas: diagnosis and surgical treatment of 74 patients. Hepatobiliary Pancreat Dis Int 1: 458-461.
132. Balzano G, Zerbi A, Veronesi P, et al. (2003) Surgical treatment of benign and borderline neoplasms of the pancreatic body. Dig Surg 20: 506-510.
133. Sarmiento JM, et al. (2002) Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 132: 976-982.
134. Kaplan EL, et al. (1990) Gastrinomas: a 42-year experience. World J Surg 14: 365-375.
135. Stacpoole PW. (1981) The glucagonoma syndrome: clinical features, diagnosis, and treatment. Endocr Rev 2: 347-361.
136. Phan GQ, et al. (1998) Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 2: 472-482.
137. Fernandez-Cruz L, et al. (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors.World J Surg 26: 1057-1065.
138. Sussman LA, Christie R, Whittle DE. (1996) Laparoscopic excision of distal pancreas including insulinoma. Aust N Z J Surg 66: 414-416.